Proteostasis Therapeutics Inc. | Mutual Funds
Mutual Funds that own Proteostasis Therapeutics Inc.
Prudential Jennison Health Sciences Fund
2,271,706
6.19%
0
0.24%
07/31/2018
Vanguard Total Stock Market Index Fund
622,010
1.7%
0
0%
07/31/2018
iShares Russell 2000 ETF
526,641
1.44%
-282
0%
09/06/2018
Vanguard Extended Market Index Fund
309,755
0.84%
0
0%
07/31/2018
iShares Russell 2000 Growth ETF
212,961
0.57%
0
0.01%
09/06/2018
Lord Abbett Micro Cap Growth Fund
146,746
0.4%
146,746
0.22%
04/30/2018
Bridgeway Ultra Small Company Market Fund
139,500
0.38%
30,000
0.09%
12/31/2017
Fidelity Spartan Extended Market Index Fund
109,237
0.3%
0
0%
07/31/2018
Franklin Biotechnology Discovery Fund
88,600
0.24%
0
0.02%
03/31/2018
87,238
0.24%
54,499
0.01%
12/31/2017
| Address |
80 Guest Street
Boston Massachusetts 02135
United States
|
|
Employees
|
- |
| Website |
http://www.proteostasis.com |
| Updated |
07/08/2019 |
| Proteostasis Therapeutics, Inc. engages in the research, development, and market of pharmaceutical products. Its medicines intend to treat cystic fibrosis, protein conformational and neurodegenerative diseases. The company was founded by William Balch, Jeffery W. |
